BeiGene, Ltd. (BGNE.O): reached a strategic agreement with Ontada, a leading provider of oncology technology, to accelerate the development and implementation of real-world evidence (RWE) to improve community understanding of the financial impact and value of oncology drugs and to provide oncology drugs to patients.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.